Renal Transplantation: Immunosuppression and Managing Allograft Rejection

Tönshoff, Burkhard; Sarwal, Minnie M.; Marks, Stephen D.; Moudgil, Asha

doi:10.1007/978-3-030-52719-8_136

Cited by 2 publications

(2 citation statements)

References 141 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the first year posttransplant, kidney function may be impaired by several factors such as rejection, urinary tract infections, drug toxicity, and viral infection, beside others [35]. It is likely that impaired allograft function leads to reduced renal filtration of MMA and lower intrarenal enzymatic activity, both of which increase plasma MMA levels driving further renal tissue injury and decline of kidney function.…”

Section: Discussionmentioning

confidence: 99%

Renal outcome and plasma methylmalonic acid levels after isolated or combined liver or kidney transplantation in patients with methylmalonic acidemia: A multicenter analysis

Strologo

Vici

Atti

et al. 2022

Molecular Genetics and Metabolism

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Renal outcome and plasma methylmalonic acid levels after isolated or combined liver or kidney transplantation in patients with methylmalonic acidemia: A multicenter analysis

Strologo

Vici

Atti

et al. 2022

Molecular Genetics and Metabolism

View full text Add to dashboard Cite

“…Access to necessary medications is vital for kidney transplant recipients to maintain graft function and prevent rejection [ 18 , 34 , 35 , 36 , 37 ]. However, insurance coverage and medication appeals can pose significant challenges.…”

Section: Medication Appealsmentioning

confidence: 99%

Enhancing Kidney Transplant Care through the Integration of Chatbot

Garcia Valencia,

Thongprayoon,

Jadlowiec

et al. 2023

Healthcare

View full text Add to dashboard Cite

Kidney transplantation is a critical treatment option for end-stage kidney disease patients, offering improved quality of life and increased survival rates. However, the complexities of kidney transplant care necessitate continuous advancements in decision making, patient communication, and operational efficiency. This article explores the potential integration of a sophisticated chatbot, an AI-powered conversational agent, to enhance kidney transplant practice and potentially improve patient outcomes. Chatbots and generative AI have shown promising applications in various domains, including healthcare, by simulating human-like interactions and generating contextually appropriate responses. Noteworthy AI models like ChatGPT by OpenAI, BingChat by Microsoft, and Bard AI by Google exhibit significant potential in supporting evidence-based research and healthcare decision making. The integration of chatbots in kidney transplant care may offer transformative possibilities. As a clinical decision support tool, it could provide healthcare professionals with real-time access to medical literature and guidelines, potentially enabling informed decision making and improved knowledge dissemination. Additionally, the chatbot has the potential to facilitate patient education by offering personalized and understandable information, addressing queries, and providing guidance on post-transplant care. Furthermore, under clinician or transplant pharmacist supervision, it has the potential to support post-transplant care and medication management by analyzing patient data, which may lead to tailored recommendations on dosages, monitoring schedules, and potential drug interactions. However, to fully ascertain its effectiveness and safety in these roles, further studies and validation are required. Its integration with existing clinical decision support systems may enhance risk stratification and treatment planning, contributing to more informed and efficient decision making in kidney transplant care. Given the importance of ethical considerations and bias mitigation in AI integration, future studies may evaluate long-term patient outcomes, cost-effectiveness, user experience, and the generalizability of chatbot recommendations. By addressing these factors and potentially leveraging AI capabilities, the integration of chatbots in kidney transplant care holds promise for potentially improving patient outcomes, enhancing decision making, and fostering the equitable and responsible use of AI in healthcare.

show abstract

Renal Transplantation: Immunosuppression and Managing Allograft Rejection

Cited by 2 publications

References 141 publications

Renal outcome and plasma methylmalonic acid levels after isolated or combined liver or kidney transplantation in patients with methylmalonic acidemia: A multicenter analysis

Renal outcome and plasma methylmalonic acid levels after isolated or combined liver or kidney transplantation in patients with methylmalonic acidemia: A multicenter analysis

Enhancing Kidney Transplant Care through the Integration of Chatbot

Contact Info

Product

Resources

About